Health :: Canada’s Clean Air Act Delivered to Canadians

The Honourable Rona Ambrose, Minister of the Environment, gave Canadians the first and central component of Canada’s New Government’s environmental Agenda when she introduced Canada’s Clean Air Act in Parliament. “We listened to Canadians. They told us they were concerned about worsening air quality and increasing emissions of greenhouse gases,” said Minister Ambrose. “After more than a decade of inaction on the environment by the previous government, Canada’s Clean Air Act is the first step in turning things around to protect the health of Canadians.”

HIV :: REYATAZ, atazanavir sulfate for Adults With HIV-1 Infection

Bristol-Myers Squibb Company (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has granted approval of a new 300 mg single capsule formulation of REYATAZ? (atazanavir sulfate) for the treatment of HIV-1 infection in adults as part of combination therapy. Taken once daily along with ritonavir and food as part of a anti-HIV drug regimen, the REYATAZ 300 mg single capsule formulation can replace two REYATAZ 150 mg capsules for: patients who have previously received anti-HIV medicines, patients who will be receiving tenofovir disoproxil fumarate, and patients who have never taken anti-HIV medicines that require SUSTIVA? (efavirenz) as part of their anti-HIV drug regimen. The REYATAZ single capsule formulation will be available in the United States within seven business days.

Hunter Syndrome :: ELAPRASE, idursulfase – therapy for Hunter syndrome patients in Europe

Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) today reported that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) issued a positive opinion recommending approval of ELAPRASE for the long-term treatment of patients with Hunter syndrome (Mucopolysaccharidosis II). The EU Marketing Authorisation is expected early in 2007 and will result in unified labelling that will be valid in the current EU 25 member states as well as in Iceland and Norway.

ADHD :: Use of Ritalin in preschoolers with attention deficit disorder

Is it safe to give preschoolers Ritalin, the popular attention deficit disorder drug? The first long-term U.S. government study of that age group warns of side effects with the stimulant drug, which isn’t recommended for children under age six. There were benefits for children who had severe ADHD, but the researchers said preschoolers on Ritalin need close monitoring because they’re more likely than older children to develop side effects.

Pregnancy :: Women with toxoplasmosis more likely to have sons

Women who carry a common parasite are more likely to give birth to boys, Czech researchers report. In most populations, 51 percent of babies born are male, Dr. S. Kankova of Charles University in Prague and colleagues note. But among a group of women infected with the bug Toxoplasma, 61 percent of babies born were boys.

Hearing Loss :: Listening to loud music with earphones harmful

Listening to loud music with earphones on a digital music player for more than 90 minutes a day can damage your hearing, according to a new U.S. study. The study of 100 doctoral students concluded that people who listened to music at 80 percent of volume capacity, at which point the sound is considered loud, should stick to under 90 minutes a day.

Sleep :: Creating Healthy Sleep Habits for your Children

This interesting article addresses some of the key issues regarding healthy sleep habits. A careful reading of this material could make a big difference in how you think about healthy sleep habits to children. Healthy sleep habits for children are as significant as they are a necessary for health, proper growth and well-being.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack